Proteins in microglial activation - inputs and outputs by subsets

Current Protein and Peptide Science

Volumn 14, Issue 1, 2013, Pages 3-15

  Hanisch, Uwe Karsten ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Chemokines; Cytokines; DAMP; Heterogeneity; MHC; Myelin; PAMP; Phagocytosis; Phenotype

Indexed keywords

CD11B ANTIGEN; CLAUDIN; CYCLOOXYGENASE 2; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; METHYL CPG BINDING PROTEIN 2; MYELIN; NERVE PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTATION; ARTICLE; CELL ACTIVATION; CELL HETEROGENEITY; EXCITOTOXICITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC DISORDER; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROGLIA; NERVE CELL PLASTICITY; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RISK FACTOR; SIGNAL TRANSDUCTION; TISSUE INJURY;

ANIMALS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; CHEMOKINES; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; MICROGLIA; PHENOTYPE;

EID: 84876701231     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/1389203711314010003     Document Type: Article

References (112)

1. Hanisch, U. K.; Kettenmann, H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci., 2007, 10 (11), 1387-1394.
2. Kettenmann, H.; Hanisch, U. K.; Noda, M.; Verkhratsky, A. Physiology of microglia. Physiol. Rev. 2011, 91, 461-553.
3. Prinz, M.; Priller, J.; Sisodia, S. S.; Ransohoff, R. M. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat. Neurosci., 2011, 13 (10), 1227-1235.
4. Fitzner, D.; Schnaars, M.; van Rossum, D.; Krishnamoorthy, G.; Dibaj, P.; Bakhti, M.; Regen, T.; Hanisch, U. K.; Simons, M. Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J. Cell Sci., 2011, 124, 447-458.
5. Wake, H.; Moorhouse, A. J.; Jinno, S.; Kohsaka, S.; Nabekura, J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci., 2009, 29 (13), 3974-3980.
6. Nimmerjahn, A.; Kirchhoff, F.; Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science, 2005, 308 (5726), 1314-1318.
7. Graeber, M. B. Changing face of microglia. Science, 2010, 330 (6005), 783-788.
8. Hanisch, U. K. Factors controlling microglial activation. In Neuroglia, Kettenmann, H., Ransom, B., Eds.; Oxford University Press: 2012; (in press).
9. Hanisch, U. K.; Johnson, T. V.; Kipnis, J. Toll-like receptors: roles in neuroprotection? Trends Neurosci., 2008, 31 (4), 176-182.
10. Hanisch, U. K. Microglia as a source and target of cytokines. Glia, 2002, 40 (2), 140-155.
11. Block, M. L.; Zecca, L.; Hong, J. S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci., 2007, 8 (1), 57-69.
12. Schwartz, M.; Butovsky, O.; Brück, W.; Hanisch, U. K. Microglial phenotype: is the commitment reversible? Trends Neurosci., 2006, 29 (2), 68-74.
13. David, S.; Kroner, A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat. Rev. Neurosci., 2011, 12 (7), 388-399.
14. Mantovani, A.; Sica, A.; Sozzani, S.; Allavena, P.; Vecchi, A.; Locati, M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol., 2004, 25 (12), 677-686.
15. Olah, M.; Biber, K.; Vinet, J.; Boddeke, H. W. Microglia phenotype diversity. CNS. Neurol. Disord. Drug Targets., 2011, 10 (1), 108-118.
16. Ransohoff, R. M.; Perry, V. H. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol., 2009, 27, 119-145.
17. Town, T.; Nikolic, V.; Tan, J. The microglial activation continuum: from innate to adaptive responses. J. Neuroinflamm., 2005, 2, 24.
18. Mosser, D. M.; Edwards, J. P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol., 2008, 8 (12), 958-969.
19. Butovsky, O.; Ziv, Y.; Schwartz, A.; Landa, G.; Talpalar, A. E.; Pluchino, S.; Martino, G.; Schwartz, M. Microglia activated by IL- 4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol. Cell Neurosci., 2006, 31 (1), 149-160.
20. Regen, T.; van Rossum, D.; Scheffel, J.; Kastriti, M. E.; Revelo, N. H.; Prinz, M.; Brück, W.; Hanisch, U. K. CD14 and TRIF govern distinct responsiveness and responses in mouse microglial TLR4 challenges by structural variants of LPS. Brain Behav. Immun., 2011, 25 (5), 957-970.
21. van Rossum, D.; Hilbert, S.; Strassenburg, S.; Hanisch, U. K.; Brück, W. Myelin-phagocytosing macrophages in isolated sciatic and optic nerves reveal a unique reactive phenotype. Glia, 2008, 56 (3), 271-283.
22. Scheffel, J.; Regen, T.; van Rossum, D.; Seifert, S.; Ribes, S.; Nau, R.; Parsa, R.; Harris, R. A.; Boddeke, H. W. G. M.; Chuang, H.-N.; Pukrop, T.; Wessels, J. T.; Jürgens, T.; Merkler, D.; Brück, W.; Schnaars, M.; Simons, M.; Kettenmann, H.; Hanisch, U. K. Tolllike receptor activation reveals developmental reorganization and unmasks responder subsets of microglia. Glia, 2012, 60, 1930-1943.
23. Davalos, D.; Grutzendler, J.; Yang, G.; Kim, J. V.; Zuo, Y.; Jung, S.; Littman, D. R.; Dustin, M. L.; Gan, W. B. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci., 2005, 8 (6), 752-758.
24. Schlegelmilch, T.; Henke, K.; Peri, F. Microglia in the developing brain: from immunity to behaviour. Curr. Opin. Neurobiol., 2011, 21 (1), 5-10.
25. Paolicelli, R. C.; Bolasco, G.; Pagani, F.; Maggi, L.; Scianni, M.; Panzanelli, P.; Giustetto, M.; Ferreira, T. A.; Guiducci, E.; Dumas, L.; Ragozzino, D.; Gross, C. T. Synaptic pruning by microglia is necessary for normal brain development. Science, 2011, 333 (6048), 1456-1458.
26. Cullheim, S.; Thams, S. The microglial networks of the brain and their role in neuronal network plasticity after lesion. Brain Res. Rev., 2007, 55 (1), 89-96.
27. Chen, S. K.; Tvrdik, P.; Peden, E.; Cho, S.; Wu, S.; Spangrude, G.; Capecchi, M. R. Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell, 2010, 141 (5), 775-785.
28. Derecki, N. C.; Cronk, J. C.; Lu, Z.; Xu, E.; Abbott, S. B.; Guyenet, P. G.; Kipnis, J. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature, 2012, 484 (7392), 105-109.
29. Monji, A.; Kato, T.; Kanba, S. Cytokines and schizophrenia: Microglia hypothesis of schizophrenia. Psychiatry Clin. Neurosci., 2009, 63 (3), 257-265.
30. Bilbo, S. D.; Schwarz, J. M. Early-life programming of later-life brain and behavior: a critical role for the immune system. Front Behav. Neurosci., 2009, 3, 14.
31. Bilbo, S. D.; Biedenkapp, J. C.; Der-Avakian, A.; Watkins, L. R.; Rudy, J. W.; Maier, S. F. Neonatal infection-induced memory impairment after lipopolysaccharide in adulthood is prevented via caspase-1 inhibition. J. Neurosci., 2005, 25 (35), 8000-8009.
32. Stolp, H. B.; Ek, C. J.; Johansson, P. A.; Dziegielewska, K. M.; Bethge, N.; Wheaton, B. J.; Potter, A. M.; Saunders, N. R. Factors involved in inflammation-induced developmental white matter damage. Neurosci. Lett., 2009, 451 (3), 232-236.
33. Butovsky, O.; Landa, G.; Kunis, G.; Ziv, Y.; Avidan, H.; Greenberg, N.; Schwartz, A.; Smirnov, I.; Pollack, A.; Jung, S.; Schwartz, M. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J. Clin. Invest., 2006, 116 (4), 905-915.
34. Ziv, Y.; Ron, N.; Butovsky, O.; Landa, G.; Sudai, E.; Greenberg, N.; Cohen, H.; Kipnis, J.; Schwartz, M. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat. Neurosci., 2006, 9 (2), 268-275.
35. van Rossum, D.; Hanisch, U. K. Microglia. Metab. Brain Dis., 2004, 19 (3-4), 393-411.
36. Biber, K.; Neumann, H.; Inoue, K.; Boddeke, H. W. Neuronal 'On' and 'Off' signals control microglia. Trends Neurosci., 2007, 30 (11), 596-602.
37. Kawai, T.; Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol., 2010, 11 (5), 373-384.
38. Takeuchi, O.; Akira, S. Pattern recognition receptors and inflammation. Cell, 2010, 140 (6), 805-820.
39. Rubartelli, A.; Lotze, M. T. Inside,outside, upside down: damageassociated molecular pattern molecules (DAMPs) and redox. Trends Immunol., 2007, 28, 429-436.
40. Lotze, M. T.; Zeh, H. J.; Rubartelli, A.; Sparvero, L. J.; Amoscato, A. A.; Washburn, N. R.; Devera, M. E.; Liang, X.; Tor, M.; Billiar, T. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol. Rev., 2007, 220, 60-81.
41. Matzinger, P. Friendly and dangerous signals: is the tissue in control? Nat. Immunol., 2007, 8 (1), 11-13.
42. Lehnardt, S.; Schott, E.; Trimbuch, T.; Laubisch, D.; Krueger, C.; Wulczyn, G.; Nitsch, R.; Weber, J. R. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J. Neurosci., 2008, 28 (10), 2320-2331.
43. Kono, H.; Rock, K. L. How dying cells alert the immune system to danger. Nat. Rev. Immunol., 2008, 8 (4), 279-289.
44. Piccinini, A. M.; Midwood, K. S. DAMPening inflammation by modulating TLR signalling. Mediators. Inflamm., 2010, 2010.
45. Zhang, X.; Mosser, D. M. Macrophage activation by endogenous danger signals. J. Pathol., 2008, 214 (2), 161-178.
46. Chen, G. Y.; Nunez, G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol., 2010, 10 (12), 826-837.
47. Stewart, C. R.; Stuart, L. M.; Wilkinson, K.; van Gils, J. M.; Deng, J.; Halle, A.; Rayner, K. J.; Boyer, L.; Zhong, R.; Frazier, W. A.; Lacy-Hulbert, A.; El, K. J.; Golenbock, D. T.; Moore, K. J. CD36 ligands promote sterile inflammation through assembly of a Tolllike receptor 4 and 6 heterodimer. Nat. Immunol., 2010, 11 (2), 155-161.
48. Källberg, E.; Vogl, T.; Liberg, D.; Olsson, A.; Bjork, P.; Wikstrom, P.; Bergh, A.; Roth, J.; Ivars, F.; Leanderson, T. S100A9 interaction with TLR4 promotes tumor growth. PLoS. One., 2012, 7 (3), e34207.
49. Chun, K. H.; Seong, S. Y. CD14 but not MD2 transmit signals from DAMP. Int. Immunopharmacol., 2010, 10 (1), 98-106.
50. Lehmann, S. M.; Kruger, C.; Park, B.; Derkow, K.; Rosenberger, K.; Baumgart, J.; Trimbuch, T.; Eom, G.; Hinz, M.; Kaul, D.; Habbel, P.; Kalin, R.; Franzoni, E.; Rybak, A.; Nguyen, D.; Veh, R.; Ninnemann, O.; Peters, O.; Nitsch, R.; Heppner, F. L.; Golenbock, D.; Schott, E.; Ploegh, H. L.; Wulczyn, F. G.; Lehnardt, S. An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat. Neurosci., 2012.
51. Iadecola, C.; Anrather, J. The immunology of stroke: from mechanisms to translation. Nat. Med., 2011, 17 (7), 796-808.
52. Weber, M. S.; Prod'homme, T.; Youssef, S.; Dunn, S. E.; Rundle, C. D.; Lee, L.; Patarroyo, J. C.; Stuve, O.; Sobel, R. A.; Steinman, L.; Zamvil, S. S. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat. Med., 2007, 13 (8), 935-943.
53. Wong, S. C.; Puaux, A. L.; Chittezhath, M.; Shalova, I.; Kajiji, T. S.; Wang, X.; Abastado, J. P.; Lam, K. P.; Biswas, S. K. Macrophage polarization to a unique phenotype driven by B cells. Eur. J. Immunol., 2010, 40 (8), 2296-2307.
54. Mikita, J.; Dubourdieu-Cassagno, N.; Deloire, M. S.; Vekris, A.; Biran, M.; Raffard, G.; Brochet, B.; Canron, M. H.; Franconi, J. M.; Boiziau, C.; Petry, K. G. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult. Scler., 2011, 17 (1), 2-15.
55. Pollard, J. W. Trophic macrophages in development and disease. Nat. Rev. Immunol., 2009, 9 (4), 259-270.
56. Treves, A. J. The origin of monocyte-macrophage heterogeneity: possible alternatives. Med. Hypotheses, 1984, 14 (4), 335-346.
57. Biswas, S. K.; Mantovani, A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol., 2010, 11 (10), 889-896.
58. Daley, J. M.; Brancato, S. K.; Thomay, A. A.; Reichner, J. S.; Albina, J. E. The phenotype of murine wound macrophages. J. Leukoc. Biol., 2010, 87 (1), 59-67.
59. Gordon, S.; Taylor, P. R. Monocyte and macrophage heterogeneity. Nat. Rev Immunol., 2005, 5 (12), 953-964.
60. Martinez, F. O.; Gordon, S.; Locati, M.; Mantovani, A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol., 2006, 177 (10), 7303-7311.
61. Martinez, F. O.; Helming, L.; Gordon, S. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol., 2009, 27, 451-483.
62. Murray, P. J.; Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol., 2011, 11 (11), 723-737.
63. Colton, C. A. Heterogeneity of microglial activation in the innate immune response in the brain. J. Neuroimmune. Pharmacol., 2009, 4 (4), 399-418.
64. Davoust, N.; Vuaillat, C.; Androdias, G.; Nataf, S. From bone marrow to microglia: barriers and avenues. Trends Immunol., 2008, 29 (5), 227-234.
65. Kigerl, K. A.; Gensel, J. C.; Ankeny, D. P.; Alexander, J. K.; Donnelly, D. J.; Popovich, P. G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci., 2009, 29 (43), 13435-13444.
66. Michelucci, A.; Heurtaux, T.; Grandbarbe, L.; Morga, E.; Heuschling, P. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta. J. Neuroimmunol., 2009, 210 (1-2), 3-12.
67. Olah, M.; Amor, S.; Brouwer, N.; Vinet, J.; Eggen, B.; Biber, K.; Boddeke, H. W. Identification of a microglia phenotype supportive of remyelination. Glia, 2012, 60 (2), 306-321.
68. Popovich, P. G.; Guan, Z.; Wei, P.; Huitinga, I.; van, R. N.; Stokes, B. T. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol., 1999, 158 (2), 351-365.
69. Pukrop, T.; Dehgani, F.; Han-Ning, C.; Lohaus, R.; Byanga, K.; Heermann, S.; Regen, T.; van Rossum, D.; Klemm, F.; Schulz, M.; Siam, L.; Hoffmann, A.; Trümper, L.; Stadelmann, C.; Bechmann, I.; Hanisch, U. K.; Binder, C. Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way. Glia, 2010, 58, 1477-1489.
70. Saijo, K.; Glass, C. K. Microglial cell origin and phenotypes in health and disease. Nat. Rev. Immunol., 2011, 11 (11), 775-787.
71. Schmid, C. D.; Sautkulis, L. N.; Danielson, P. E.; Cooper, J.; Hasel, K. W.; Hilbush, B. S.; Sutcliffe, J. G.; Carson, M. J. Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia. J. Neurochem., 2002, 83 (6), 1309-1320.
72. Tierney, J. B.; Kharkrang, M.; La Flamme, A. C. Type II-activated macrophages suppress the development of experimental autoimmune encephalomyelitis. Immunol. Cell Biol., 2009, 87 (3), 235-240.
73. Ponomarev, E. D.; Maresz, K.; Tan, Y.; Dittel, B. N. CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J. Neurosci., 2007, 27 (40), 10714-10721.
74. Starossom, S. C.; Mascanfroni, I. D.; Imitola, J.; Cao, L.; Raddassi, K.; Hernandez, S. F.; Bassil, R.; Croci, D. O.; Cerliani, J. P.; Delacour, D.; Wang, Y.; Elyaman, W.; Khoury, S. J.; Rabinovich, G. A. Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity, 2012, 37 (2), 249-263.
75. Zhou, X.; Spittau, B.; Krieglstein, K. TGFbeta signalling plays an important role in IL-4-induced alternative activation of microglia. J. Neuroinflamm., 2012, 9, 210.
76. Colton, C. A.; Mott, R. T.; Sharpe, H.; Xu, Q.; Van Nostrand, W. E.; Vitek, M. P. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J. Neuroinflamm., 2006, 3, 27.
77. Edwards, J. P.; Zhang, X.; Frauwirth, K. A.; Mosser, D. M. Biochemical and functional characterization of three activated macrophage populations. J. Leukoc. Biol., 2006, 80 (6), 1298-1307.
78. Anderson, C. F.; Gerber, J. S.; Mosser, D. M. Modulating macrophage function with IgG immune complexes. J. Endotoxin. Res., 2002, 8 (6), 477-481.
79. Anderson, C. F.; Mosser, D. M. A novel phenotype for an activated macrophage: the type 2 activated macrophage. J. Leukoc. Biol., 2002, 72 (1), 101-106.
80. Gerber, J. S.; Mosser, D. M. Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors. J. Immunol., 2001, 166 (11), 6861-6868.
81. Chang, N. C.; Hung, S. I.; Hwa, K. Y.; Kato, I.; Chen, J. E.; Liu, C. H.; Chang, A. C. A macrophage protein, Ym1, transiently expressed during inflammation is a novel mammalian lectin. J. Biol. Chem., 2001, 276 (20), 17497-17506.
82. Maresz, K.; Ponomarev, E. D.; Barteneva, N.; Tan, Y.; Mann, M. K.; Dittel, B. N. IL-13 induces the expression of the alternative activation marker Ym1 in a subset of testicular macrophages. J. Reprod. Immunol., 2008, 78 (2), 140-148.
83. Raes, G.; De, B. P.; Noel, W.; Beschin, A.; Brombacher, F.; Hassanzadeh, G. G. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J. Leukoc. Biol., 2002, 71 (4), 597-602.
84. Raes, G.; Brys, L.; Dahal, B. K.; Brandt, J.; Grooten, J.; Brombacher, F.; Vanham, G.; Noel, W.; Bogaert, P.; Boonefaes, T.; Kindt, A.; Van den, B. R.; Leenen, P. J.; De, B. P.; Ghassabeh, G. H. Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation. J. Leukoc. Biol., 2005, 77 (3), 321-327.
85. Van den Bossche J.; Laoui, D.; Morias, Y.; Movahedi, K.; Raes, G.; De, B. P.; Van Ginderachter, J. A. Claudin-1, claudin-2 and claudin-11 genes differentially associate with distinct types of antiinflammatory macrophages in vitro and with parasite- and tumourelicited macrophages in vivo. Scand. J. Immunol., 2012, 75 (6), 588-598.
86. Ponomarev, E. D.; Shriver, L. P.; Dittel, B. N. CD40 expression by microglial cells is required for their completion of a two-step activation process during central nervous system autoimmune inflammation. J. Immunol., 2006, 176 (3), 1402-1410.
87. Gomez Perdiguero, E.; Schulz, C.; Geissmann, F. Development and homeostasis of resident myeloid cells: The case of the microglia. Glia, 2012.
88. Schulz, C.; Gomez, P. E.; Chorro, L.; Szabo-Rogers, H.; Cagnard, N.; Kierdorf, K.; Prinz, M.; Wu, B.; Jacobsen, S. E.; Pollard, J. W.; Frampton, J.; Liu, K. J.; Geissmann, F. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science, 2012, 336 (6077), 86-90.
89. Greter, M.; Merad, M. Regulation of microglia development and homeostasis. Glia, 2012.
90. Ginhoux, F.; Greter, M.; Leboeuf, M.; Nandi, S.; See, P.; Gokhan, S.; Mehler, M. F.; Conway, S. J.; Ng, L. G.; Stanley, E. R.; Samokhvalov, I. M.; Merad, M. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science, 2010, 330 (6005), 841-845.
91. Mildner, A.; Schmidt, H.; Nitsche, M.; Merkler, D.; Hanisch, U. K.; Mack, M.; Heikenwalder, M.; Brück, W.; Priller, J.; Prinz, M. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat. Neurosci., 2007, 10 (12), 1544-1553.
92. de Haas, A. H.; Boddeke, H. W.; Biber, K. Region-specific expression of immunoregulatory proteins on microglia in the healthy CNS. Glia, 2008, 56 (8), 888-894.
93. Lawson, L. J.; Perry, V. H.; Dri, P.; Gordon, S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience, 1990, 39 (1), 151-170.
94. Ponomarev, E. D.; Shriver, L. P.; Maresz, K.; Dittel, B. N. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J. Neurosci Res., 2005, 81 (3), 374-389.
95. Kim, W. G.; Mohney, R. P.; Wilson, B.; Jeohn, G. H.; Liu, B.; Hong, J. S. Regional differences in susceptability to lipopolysaccharide- induced neurotoxicity in the rat brain: role of microglia. J. Neurosci., 2011, 20, 6303-6316.
96. van Weering, H. R.; Boddeke, H. W.; Vinet, J.; Brouwer, N.; de Haas, A. H.; van, R. N.; Thomsen, A. R.; Biber, K. P. CXCL10/CXCR3 signaling in glia cells differentially affects NMDA-induced cell death in CA and DG neurons of the mouse hippocampus. Hippocampus, 2010.
97. Schmid, C. D.; Melchior, B.; Masek, K.; Puntambekar, S. S.; Danielson, P. E.; Lo, D. D.; Sutcliffe, J. G.; Carson, M. J. Differential gene expression in LPS/IFNgamma activated microglia and macrophages: in vitro versus in vivo. J. Neurochem., 2009, 109 Suppl 1, 117-125.
98. Matyash, V.; Kettenmann, H. Heterogeneity in astrocyte morphology and physiology. Brain Res. Rev., 2010, 63 (1-2), 2-10.
99. Landgraf, M.; Evers, J. F. Control of dendritic diversity. Curr. Opin. Cell Biol., 2005, 17 (6), 690-696.
100. Kaul, D.; Habbel, P.; Derkow, K.; Kruger, C.; Franzoni, E.; Wulczyn, F. G.; Bereswill, S.; Nitsch, R.; Schott, E.; Veh, R.; Naumann, T.; Lehnardt, S. Expression of Toll-like receptors in the developing brain. PLoS. One., 2012, 7 (5), e37767.
101. Neumann, H.; Cavalie, A.; Jenne, D. E.; Wekerle, H. Induction of MHC class I genes in neurons. Science, 1995, 269 (5223), 549-552.
102. Glynn, M. W.; Elmer, B. M.; Garay, P. A.; Liu, X. B.; Needleman, L. A.; El-Sabeawy, F.; McAllister, A. K. MHCI negatively regulates synapse density during the establishment of cortical connections. Nat. Neurosci., 2011, 14 (4), 442-451.
103. Ribes, S.; Ebert, S.; Regen, T.; Agarwal, A.; Tauber, S. C.; Czesnik, D.; Spreer, A.; Bunkowski, S.; Eiffert, H.; Hanisch, U. K.; Hammerschmidt, S.; Nau, R. Toll-like receptor stimulation enhances phagocytosis and intracellular killing of nonencapsulated and encapsulated Streptococcus pneumoniae by murine microglia. Infect. Immun., 2010, 78 (2), 865-871.
104. Ribes, S.; Ebert, S.; Czesnik, D.; Regen, T.; Zeug, A.; Bukowski, S.; Mildner, A.; Eiffert, H.; Hanisch, U. K.; Hammerschmidt, S.; Nau, R. Toll-like receptor prestimulation increases phagocytosis of Escherichia coli DH5alpha and Escherichia coli K1 strains by murine microglial cells. Infect. Immun., 2009, 77 (1), 557-564.
105. Ribes, S.; Ebert, S.; Regen, T.; Czesnik, D.; Scheffel, J.; Zeug, A.; Bunkowski, S.; Eiffert, H.; Hanisch, U. K.; Hammerschmidt, S.; Nau, R. Fibronectin stimulates Escherichia coli phagocytosis by microglial cells. Glia, 2010, 58 (3), 367-376.
106. Ribes, S.; Adam, N.; Ebert, S.; Regen, T.; Bunkowski, S.; Hanisch, U. K.; Nau, R. The viral TLR3 agonist poly(I:C) stimulates phagocytosis and intracellular killing of Escherichia coli by microglial cells. Neurosci. Lett., 2011, 482 (17), 20.
107. Liu, X.; Zhan, Z.; Li, D.; Xu, L.; Ma, F.; Zhang, P.; Yao, H.; Cao, X. Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk. Nat. Immunol., 2011, 12 (5), 416-424.
108. Snijder, B.; Sacher, R.; Ramo, P.; Damm, E. M.; Liberali, P.; Pelkmans, L. Population context determines cell-to-cell variability in endocytosis and virus infection. Nature, 2009, 461 (7263), 520-523.
109. Holm, T. H.; Draeby, D.; Owens, T. Microglia are required for astroglial Toll-like receptor 4 response and for optimal TLR2 and TLR3 response. Glia, 2012, 60 (4), 630-638.
110. Goings, G. E.; Greisman, A.; James, R. E.; Abram, L. K.; Begolka, W. S.; Miller, S. D.; Szele, F. G. Hematopoietic cell activation in the subventricular zone after Theiler's virus infection. J. Neuroinflammation., 2008, 5, 44.
111. Goings, G. E.; Kozlowski, D. A.; Szele, F. G. Differential activation of microglia in neurogenic versus non-neurogenic regions of the forebrain. Glia, 2006, 54 (4), 329-342.
112. Streit, W. J.; Miller, K. R.; Lopes, K. O.; Njie, E. Microglial degeneration in the aging brain-bad news for neurons? Front Biosci., 2008, 13, 3423-3438.